Literature DB >> 27495843

Indirect Bypass Surgery May Be More Beneficial for Symptomatic Patients with Moyamoya Disease at Early Suzuki Stage.

Lin Wang1, Cong Qian1, Xiaobo Yu1, Xiongjie Fu1, Ting Chen1, Chi Gu1, Jingyin Chen1, Gao Chen2.   

Abstract

OBJECTIVE: Moyamoya disease is a progressive stenosis or occlusion of the internal carotid artery. Revascularization surgery is considered the standard treatment. We conducted a retrospective study in hopes of finding indications for electing different surgical methods.
METHODS: A total of 55 hemispheres in 49 patients who received revascularization surgery between January 2013 and December 2015 were included. Medical data such as age and sex were extracted and risk factor analysis for vascular anastomosis patency was conducted with multivariable logistic regression.
RESULTS: In this study, direct or combined bypass surgery had a higher incidence of perioperative neurologic defects than did indirect surgery (30.3% vs. 4.5%; P = 0.046). The rates of postsurgery stroke (6.2% vs. 18.2%) and modified Rankin Scale improvement (39.4% vs. 18.2%) were better in the direct or combined bypass surgery group, but no significant difference was found. Moreover, longer operative time (209 ± 29.4 minutes vs. 101 ± 16.5 minutes; P < 0.01) and longer hospital stay (9.0 ± 3.11 days vs. 5.3 ± 2.03 days; P < 0.01) made direct or combined bypass surgery less advantageous. Multivariable binary logistic regression showed that the late Suzuki stage is a more favorable factor than the early Suzuki stage (odd ratio, 7.78; confidence interval, 1.059-57.155; P = 0.044).
CONCLUSIONS: Because vascular anastomosis patency in symptomatic patients with moyamoya disease at early Suzuki stage is relatively lower, indirect bypass surgery may be more beneficial for these patients in view of shorter operative time and hospital stay.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Bypass surgery; Cerebrovascular disease; Moyamoya disease; Suzuki stage; Vascular anastomosis patency

Mesh:

Year:  2016        PMID: 27495843     DOI: 10.1016/j.wneu.2016.07.087

Source DB:  PubMed          Journal:  World Neurosurg        ISSN: 1878-8750            Impact factor:   2.104


  3 in total

1.  Clinical Use of Cerebrovascular Compliance Imaging to Evaluate Revascularization in Patients With Moyamoya.

Authors:  Jennifer M Watchmaker; Blaise deB Frederick; Matthew R Fusco; Larry T Davis; Meher R Juttukonda; Sarah K Lants; Howard S Kirshner; Manus J Donahue
Journal:  Neurosurgery       Date:  2019-01-01       Impact factor: 4.654

2.  Analysis of the clinical characteristics of hemorrhagic moyamoya disease in the Jilin province of northeastern China: A single-center study of 212 cases.

Authors:  Qinglian Li; Lai Qu; Yongjie Yuan; Baofeng Xu; Yunbao Guo; Kan Xu; Jinlu Yu
Journal:  Biomed Rep       Date:  2017-12-15

3.  Predictors of preoperative cognitive dysfunction in adults with Moyamoya disease: a preliminary research.

Authors:  Jian Sun; Zhiyong Shi; Lebao Yu; Yujie Wen; Dong Zhang
Journal:  BMC Neurol       Date:  2022-01-06       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.